CI

Coromandel Inter

Q1 FY27Fertilizers & Agrochemicals

Coromandel Inter Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹1,913
Market cap₹58.9K Cr
P/E31.5
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

1 of 4 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned
FundraiseNo fundraise planned

The short version

Specialty Nutrient business growing consistently at 25%-30% with high EBITDA margins (~20%). Specialty Nutrient business is growing at 25%-30% with an EBITDA margin of 20%, expected to gain further traction especially in water-soluble grades for drip irrigation.

From Coromandel Inter's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Moderate growth
  • Specialty Nutrient business growing consistently at 25%-30% with high EBITDA margins (~20%). Expansion in MAP and granulation capacities expected to boost product portfolio with high-margin products gaining traction.
  • Targeting 50% of fertilizer sales volume (~750,000 tonnes capacity) through own retail outlets with expanded footprint in key states (Maharashtra, Tamil Nadu, Andhra, Telangana); new markets being seeded in UP, Rajasthan, MP, Chhattisgarh for remaining volumes.
  • Nano DAP business holds ~60% market share; exports initiated with plans to expand international presence once regulatory approvals are secured.
  • Drone (Dhaksha) business is focusing on agri-drones with fleet expansion to 500 drones during the year, aiming for higher adoption in precision agriculture.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Coromandel Inter said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Coromandel plans no immediate fertilizer capacity addition; focus is on generating cash from recent investments amid geopolitical challenges.
  • Current fertilizer capacity aimed at 4 million tons plus 1 million tons trading (mainly DAP) and 1 million tons of SSP, organic, urea, and imported DAP covering 8-9 million tons for next 2 years.
  • Seeking opportunities for additional land for future expansion; discussions ongoing with Andhra Pradesh government.
  • Specialty nutrient business is investing in MAP plant at Kakinada (to be operational in about 1 year) for raw material sourcing and trading.
  • Evaluating projects like purified phosphoric acid for battery chemicals; dependent on commercial viability.
  • Crop protection business completed capacity expansion; focus shifts to marketing, brand building, and channel network rather than new capacity.

2 more points management made on capital expenditure plans

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Coromandel Inter said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Coromandel International does not explicitly mention a current or expected order book or pending orders in the provided transcript.
  • The company indicates strong visibility for fertilizer demand: planning to sell up to 4 million tons of fertilizers and 1 million tons of trading (mostly DAP) over the next couple of years.
  • They have high visibility of 8-9 million tons of nutrient demand, which should support the business for the next 2 years.
  • Expansion plans are cautious given recent geopolitical and margin pressures; no immediate capacity additions planned.

2 more points management made on order book & pipeline

Coromandel Inter — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹6.0K Cr, net profit ₹115 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Advance Agrolife Ltd (Q1 FY27)

    Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…

  • Bhagiradha Chemicals & Industries Ltd (Q1 FY27)

    195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Sumitomo Chemical India Ltd (Q1 FY27)

    1,063.3 crore, a 1% year-on-year (YoY) increase from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q1 FY27 earnings call — and how it ranks…

  • Dharmaj Crop Guard Ltd (Q1 FY27)

    Revenue from Operations for Q1 FY27: ₹3,841 Mn, a 5% increase YoY from ₹3,674 Mn in Q1 FY26. Key concall takeaways from Dharmaj Crop Guard Ltd's Q1 FY27…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Coromandel Inter Q1 FY27 results?

Specialty Nutrient business growing consistently at 25%-30% with high EBITDA margins (~20%). Specialty Nutrient business is growing at 25%-30% with an EBITDA margin of 20%, expected to gain further traction especially in water-soluble grades for drip irrigation.

What is Coromandel Inter share price analysis?

Coromandel Inter currently shows a below-average growth signal. The stock trades at a P/E of 31.5 with a market cap of ₹58,888 Cr. Investors should review the full earnings analysis for detailed insights.

Is Coromandel Inter planning capital expenditure?

Coromandel plans no immediate fertilizer capacity addition; focus is on generating cash from recent investments amid geopolitical challenges.

Keep Coromandel Inter on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.